منوی کاربری
  • پشتیبانی: ۴۲۲۷۳۷۸۱ - ۰۴۱
  • سبد خرید

دانلود رایگان مقاله ساختار گلیکان فاکتور فعال ماکروفاژ مشتق شده از پروتئین GC

عنوان فارسی
ساختار گلیکان فاکتور فعال ماکروفاژ مشتق شده از پروتئین GC به عنوان منکشف توسط طیف سنجی جرمی
عنوان انگلیسی
Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry
صفحات مقاله فارسی
0
صفحات مقاله انگلیسی
13
سال انتشار
2016
نشریه
الزویر - Elsevier
فرمت مقاله انگلیسی
PDF
کد محصول
E352
رشته های مرتبط با این مقاله
زیست شناسی
گرایش های مرتبط با این مقاله
علوم سلولی مولکولی و بیو شیمی
مجله
آرشیو بیوشیمی و بیوفیزیک - Archives of Biochemistry and Biophysics
دانشگاه
دانشکده علوم مولکولی، دانشگاه ایالتی آریزونا، ایالات متحده
کلمات کلیدی
ویتامین D پروتئین اتصالی، GcMAF، تری ساکارید خطی، دی ساکارید، ESI-MS، تجزیه و تحلیل حلقه های زنجیر
۰.۰ (بدون امتیاز)
امتیاز دهید
چکیده

Abstract


Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein-derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of β-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coli β-galactosidase cleaves nothing from the protein—leaving the glycan structure of active GcMAF as a Gal-GalNAc-Thr disaccharide, regardless of the order in which β-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that α-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GalNAc-Thr monosaccharide—precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo.

نتیجه گیری

4. Conclusions


The primary O-glycan of GcMAF derived from the 1F allele product is a Gal-b(1-3)-GalNAc-Thr disaccharide and not a GalNAcThr monosaccharide as has long been believed based on inference from activity studies. This disaccharide is derived from the common sialylated core 1 O-glycanda linear trisaccharide in which the sialic acid residue is attached to galactose at its 3-position. Indeed, based on glycosidase digestion studies followed by analysis of the intact protein by ESI-MS as well as glycan linkage analysis data presented here, both the Gc1F and Gc1S trisaccharides are linear, sialylated core 1 O-glycans (i.e., NeuNAc-(2-3)-Gal-(1-3)-GalNAc-Thr) and neither contains mannose. Moreover, a-N-Acetylgalactosamindase (nagalase) lacks endoglycosidase activity and is only capable of removing the DBP O-glycan GalNAc residue once the glycan has been trimmed down to just the single reducing-end GalNAc residueda result that corroborates previous findings demonstrating that DBP is not deglycosylated in cancer patients.


بدون دیدگاه